Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 01-2026 | 01-2025 | 01-2024 | 01-2023 | 01-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | 0 | 0 | 18 | 18 |
| Accounts receivable | 9 | 28 | -22 | 310 | 181 |
| Accounts payable and accrued liabilities | 242 | 109 | -702 | 2,213 | -1,158 |
| Other Working Capital | 1,213 | 753 | 322 | 3,434 | -1,316 |
| Other Operating Activity | -2,089 | -2,911 | -2,070 | -7,478 | -8,928 |
| Operating Cash Flow | $-625 | $-2,022 | $-2,472 | $-1,504 | $-11,203 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 411 | N/A | N/A | 0 | N/A |
| Debt Issued | 0 | 1,224 | 300 | 0 | 120 |
| Debt Repayment | -5 | N/A | N/A | 0 | -250 |
| Common Stock Issued | 0 | 705 | 2,202 | 833 | 11,441 |
| Other Financing Activity | 223 | 63 | 0 | 503 | -77 |
| Financing Cash Flow | $629 | $1,993 | $2,502 | $1,336 | $11,234 |
| Exchange Rate Effect | 1 | 0 | 0 | 2 | -12 |
| Beginning Cash Position | 8 | 37 | 8 | 174 | 155 |
| End Cash Position | 13 | 8 | 37 | 8 | 174 |
| Net Cash Flow | $4 | $-29 | $29 | $-168 | $31 |
| Free Cash Flow | |||||
| Operating Cash Flow | -625 | -2,022 | -2,472 | -1,504 | -11,203 |
| Free Cash Flow | -625 | -2,022 | -2,472 | -1,504 | -11,203 |